Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS) (vol 43, pg 17, 2020)

被引：1
|
作者：
Patek, Taylor M. [1 ,2 ]
Teng, Chengwen [1 ,2 ]
Kennedy, Kaitlin E. [1 ,2 ]
Alvarez, Carlos A. [3 ]
Frei, Christopher R. [1 ,2 ,4 ,5 ]
机构：
[1] Univ Texas Austin, Pharmacotherapy Div, Coll Pharm, San Antonio, TX USA
[2] Univ Texas Hlth Sci Ctr San Antonio, Pharmacotherapy Educ & Res Ctr, Long Sch Med, 7703 Floyd Curl Dr,MSC-6220, San Antonio, TX 78229 USA
[3] Texas Tech Univ, Hlth Sci Ctr, Div Clin Translat Res, Hodge Sch Pharm, Dallas, TX USA
[4] South Texas Vet Hlth Care Syst, San Antonio, TX USA
[5] Univ Hlth Syst, San Antonio, TX USA
来源：
DRUG SAFETY | 2020年 / 43卷 / 08期
关键词：
D O I：
10.1007/s40264-020-00971-y
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
In the original publication of the article, the second sentence in the figure 2 caption should read as below:
引用
收藏
页码：825 / 825
页数：1
相关论文
共 50 条
  • [1] Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
    Patek, Taylor M.
    Teng, Chengwen
    Kennedy, Kaitlin E.
    Alvarez, Carlos A.
    Frei, Christopher R.
    DRUG SAFETY, 2020, 43 (01) : 17 - 22
  • [2] Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
    Taylor M. Patek
    Chengwen Teng
    Kaitlin E. Kennedy
    Carlos A. Alvarez
    Christopher R. Frei
    Drug Safety, 2020, 43 : 17 - 22
  • [3] Correction to: Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
    Taylor M. Patek
    Chengwen Teng
    Kaitlin E. Kennedy
    Carlos A. Alvarez
    Christopher R. Frei
    Drug Safety, 2020, 43 : 825 - 825
  • [4] Delirium Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
    Chengwen Teng
    Christopher R. Frei
    Drugs - Real World Outcomes, 2022, 9 : 23 - 29
  • [5] Rhabdomyolysis Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
    Teng, Chengwen
    Baus, Courtney
    Wilson, James P.
    Frei, Christopher R.
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2019, 16 (11): : 1504 - 1509
  • [6] Delirium Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
    Teng, Chengwen
    Frei, Christopher R.
    DRUGS-REAL WORLD OUTCOMES, 2022, 9 (01) : 23 - 29
  • [7] A pharmacovigilance study of olanzapine/samidorphan based on FDA Adverse Event Reporting System (FAERS)
    He, Luyao
    Shen, Mengting
    Zhang, Lei
    Li, Yan
    Li, Huafang
    BMC PHARMACOLOGY & TOXICOLOGY, 2025, 26 (01):
  • [8] Compartment syndrome associations with drugs: a pharmacovigilance study of the FDA adverse event reporting system (FAERS)
    Kong, Wenqiang
    Shu, Yunfeng
    Tang, Juan
    Wan, Jie
    Yang, Xueting
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [9] A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) for gemcitabine
    Zhang, Cheng
    Li, Ke
    Xu, Shu-Ning
    Qiao, Lei
    Ren, Yu-Lin
    Li, Qun
    Liu, Ying
    EXPERT OPINION ON DRUG SAFETY, 2025, 24 (03) : 365 - 376
  • [10] A REALWORLD PHARMACOVIGILANCE STUDY OF FDA ADVERSE EVENT REPORTING SYSTEM (FAERS) EVENTS FOR EMPAGLIFLOZIN AND DAPAGLIFLOZIN
    Milutinovic, Stefan
    Petrovic, Marija
    Jancic, Predrag
    Trajkovic, Hristina
    Alarcon, Ricardo Orlando Escarcega
    Chazal, Richard A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 319 - 319
12345